Foreign Institutional Investors (FIIs) have been actively reshuffling their portfolios in the latest quarter, increasing their stakes in several Indian companies across sectors. The latest data highlights stocks that witnessed a notable quarter-on-quarter increase in FII holdings, signaling growing confidence from global investors.
Top Gainers in FII Holdings
- Sudarshan Pharma Industries Ltd led the pack with a sharp 5.38% rise in FII holding, taking their total ownership to 18.45%.
- CarTrade Tech Ltd followed closely with a 5.84% jump, reaching a substantial 60.96% FII holding.
- Yasho Industries Ltd also saw strong FII interest, with a 5.83% increase, now at 7.24% total holding.
- Restaurant Brands Asia Ltd reported a 5.03% rise, pushing FII ownership to 20.37%.
- Sammaan Capital Ltd observed a 5.16% uptick, with total FII holding at 24.69%.
Other Notable Increases
- Azad Engineering Ltd experienced a 4.25% rise, bringing its FII share to 14.23%.
- Aditya Birla Fashion & Retail Ltd saw an increase of 3.85%, totaling 22.20%.
- JB Chemicals & Pharmaceuticals Ltd witnessed a 3.66% bump, reaching 18.30%.
- RBL Bank Ltd recorded a 3.13% rise in FII holding, now at 14.43%.
Moderate Gains in FII Holdings
Several mid- and small-cap companies also benefited from rising FII interest:
- Poonawalla Fincorp Ltd (+1.80%), Orient Cement Ltd (+1.65%), and 360 ONE WAM Ltd (+1.06%) all reported healthy increases.
- Notably, 360 ONE WAM Ltd already had a high FII holding of 67.22%, suggesting continued strong institutional faith.
- L&T Technology Services Ltd (+0.99%) and Tips Industries Ltd (+0.81%) were among the others recording steady growth.
Mild Uptick Observed
- Companies like Delta Corp Ltd (+0.46%), Reliance Industrial Infrastructure Ltd (+0.36%), and E2E Networks Ltd (+0.78%) saw smaller yet positive changes in FII holdings.
The rise in FII holdings is often interpreted as a positive signal, reflecting international investors’ optimism about a company’s future prospects. Stocks like CarTrade Tech, 360 ONE WAM, and Sudarshan Pharma witnessing significant buying could hint at strong fundamentals or future growth expectations. However, retail investors should conduct their own research and consider valuations before making investment decisions based solely on FII movements.
